Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Infect Immun ; 80(3): 914-20, 2012 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-22232190

RESUMO

Escherichia coli O157:H7 causes food and waterborne enteric infections that can result in hemorrhagic colitis and life-threatening hemolytic uremic syndrome. Intimate adherence of the bacteria to intestinal epithelial cells is mediated by intimin, but E. coli O157:H7 also possess several other putative adhesins, including curli and two operons that encode long polar fimbriae (Lpf). To assess the importance of Lpf for intestinal colonization, we performed competition experiments between E. coli O157:H7 and an isogenic ΔlpfA1 ΔlpfA2 double mutant in the infant rabbit model. The mutant was outcompeted in the ileum, cecum, and midcolon, suggesting that Lpf contributes to intestinal colonization. In contrast, the ΔlpfA1 ΔlpfA2 mutant showed increased adherence to colonic epithelial cells in vitro. Transmission electron microscopy revealed curli-like structures on the surface of the ΔlpfA1 ΔlpfA2 mutant, and the presence of curli was confirmed by Congo red binding, immunogold-labeling electron microscopy, immunoblotting, and quantitative real-time reverse transcription-PCR (qRT-PCR) measuring csgA expression. However, deletion of csgA, which encodes the major curli subunit, does not appear to affect intestinal colonization. In addition to suggesting that Lpf can contribute to EHEC intestinal colonization, our observations indicate that the regulatory pathways governing the expression of Lpf and curli are interdependent.


Assuntos
Adesinas Bacterianas/metabolismo , Aderência Bacteriana , Proteínas de Bactérias/metabolismo , Escherichia coli O157/patogenicidade , Proteínas de Escherichia coli/metabolismo , Proteínas de Fímbrias/metabolismo , Fímbrias Bacterianas/metabolismo , Adesinas Bacterianas/genética , Adesinas Bacterianas/ultraestrutura , Animais , Animais Recém-Nascidos , Proteínas de Bactérias/genética , Ceco/microbiologia , Linhagem Celular , Extensões da Superfície Celular/ultraestrutura , Colo/microbiologia , Células Epiteliais/microbiologia , Escherichia coli O157/genética , Escherichia coli O157/ultraestrutura , Proteínas de Escherichia coli/genética , Proteínas de Fímbrias/genética , Fímbrias Bacterianas/genética , Fímbrias Bacterianas/ultraestrutura , Deleção de Genes , Perfilação da Expressão Gênica , Humanos , Íleo/microbiologia , Coelhos
2.
Infect Immun ; 78(4): 1740-9, 2010 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-20123712

RESUMO

Enterotoxigenic Escherichia coli (ETEC) produces the ADP-ribosyltransferase toxin known as heat-labile enterotoxin (LT). In addition to the toxic effect of LT resulting in increases of cyclic AMP (cAMP) and disturbance of cellular metabolic processes, this toxin promotes bacterial adherence to intestinal epithelial cells (A. M. Johnson, R. S. Kaushik, D. H. Francis, J. M. Fleckenstein, and P. R. Hardwidge, J. Bacteriol. 191:178-186, 2009). Therefore, we hypothesized that the identification of a compound that inhibits the activity of the toxin would have a suppressive effect on the ETEC colonization capabilities. Using in vivo and in vitro approaches, we present evidence demonstrating that a fluorenone-based compound, DC5, which inhibits the accumulation of cAMP in intoxicated cultured cells, significantly decreases the colonization abilities of adenylyl cyclase toxin-producing bacteria, such as ETEC. These findings established that DC5 is a potent inhibitor both of toxin-induced cAMP accumulation and of ETEC adherence to epithelial cells. Thus, DC5 may be a promising compound for treatment of diarrhea caused by ETEC and other adenylyl cyclase toxin-producing bacteria.


Assuntos
Inibidores de Adenilil Ciclases , Adesinas Bacterianas/metabolismo , Toxinas Bacterianas/antagonistas & inibidores , Escherichia coli Enterotoxigênica/patogenicidade , Enterotoxinas/antagonistas & inibidores , Inibidores Enzimáticos/administração & dosagem , Infecções por Escherichia coli/prevenção & controle , Proteínas de Escherichia coli/antagonistas & inibidores , Animais , Aderência Bacteriana/efeitos dos fármacos , Linhagem Celular , Contagem de Colônia Microbiana , Inibidores Enzimáticos/farmacologia , Inibidores Enzimáticos/toxicidade , Células Epiteliais/microbiologia , Feminino , Fluorenos/administração & dosagem , Fluorenos/farmacologia , Fluorenos/toxicidade , Humanos , Concentração Inibidora 50 , Intestino Delgado/microbiologia , Intestino Delgado/patologia , Macrófagos/microbiologia , Camundongos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA